Global Cancer Genome Sequencing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Cancer Genome Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Cancer Genome Sequencing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Treatment accounting for % of the Cancer Genome Sequencing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Second Generation segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cancer Genome Sequencing include Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences, and Abbott Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Genome Sequencing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Second Generation
Third Generation
Market segment by Application, can be divided into
Treatment
Research
Market segment by players, this report covers
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Genome Sequencing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Genome Sequencing, with revenue, gross margin and global market share of Cancer Genome Sequencing from 2019 to 2022.
Chapter 3, the Cancer Genome Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Genome Sequencing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cancer Genome Sequencing research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Cancer Genome Sequencing
1.2 Classification of Cancer Genome Sequencing by Type
1.2.1 Overview: Global Cancer Genome Sequencing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Cancer Genome Sequencing Revenue Market Share by Type in 2021
1.2.3 Second Generation
1.2.4 Third Generation
1.3 Global Cancer Genome Sequencing Market by Application
1.3.1 Overview: Global Cancer Genome Sequencing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Treatment
1.3.3 Research
1.4 Global Cancer Genome Sequencing Market Size & Forecast
1.5 Global Cancer Genome Sequencing Market Size and Forecast by Region
1.5.1 Global Cancer Genome Sequencing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Cancer Genome Sequencing Market Size by Region, (2017-2022)
1.5.3 North America Cancer Genome Sequencing Market Size and Prospect (2017-2028)
1.5.4 Europe Cancer Genome Sequencing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Cancer Genome Sequencing Market Size and Prospect (2017-2028)
1.5.6 South America Cancer Genome Sequencing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Cancer Genome Sequencing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Genome Sequencing Market Drivers
1.6.2 Cancer Genome Sequencing Market Restraints
1.6.3 Cancer Genome Sequencing Trends Analysis
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Cancer Genome Sequencing Product and Solutions
2.1.4 Agilent Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 GE Healthcare Life Sciences
2.2.1 GE Healthcare Life Sciences Details
2.2.2 GE Healthcare Life Sciences Major Business
2.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Product and Solutions
2.2.4 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 GE Healthcare Life Sciences Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Cancer Genome Sequencing Product and Solutions
2.3.4 Johnson & Johnson Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 LI-COR Biosciences
2.4.1 LI-COR Biosciences Details
2.4.2 LI-COR Biosciences Major Business
2.4.3 LI-COR Biosciences Cancer Genome Sequencing Product and Solutions
2.4.4 LI-COR Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 LI-COR Biosciences Recent Developments and Future Plans
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories Cancer Genome Sequencing Product and Solutions
2.5.4 Abbott Laboratories Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Abbott Laboratories Recent Developments and Future Plans
2.6 Beckman Coulter
2.6.1 Beckman Coulter Details
2.6.2 Beckman Coulter Major Business
2.6.3 Beckman Coulter Cancer Genome Sequencing Product and Solutions
2.6.4 Beckman Coulter Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Beckman Coulter Recent Developments and Future Plans
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business
2.7.3 Bayer Cancer Genome Sequencing Product and Solutions
2.7.4 Bayer Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Bayer Recent Developments and Future Plans
2.8 Hamilton Thorne Biosciences
2.8.1 Hamilton Thorne Biosciences Details
2.8.2 Hamilton Thorne Biosciences Major Business
2.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Product and Solutions
2.8.4 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Hamilton Thorne Biosciences Recent Developments and Future Plans
2.9 Integrated DNA Technologies
2.9.1 Integrated DNA Technologies Details
2.9.2 Integrated DNA Technologies Major Business
2.9.3 Integrated DNA Technologies Cancer Genome Sequencing Product and Solutions
2.9.4 Integrated DNA Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Integrated DNA Technologies Recent Developments and Future Plans
2.10 Microchip Biotechnologies
2.10.1 Microchip Biotechnologies Details
2.10.2 Microchip Biotechnologies Major Business
2.10.3 Microchip Biotechnologies Cancer Genome Sequencing Product and Solutions
2.10.4 Microchip Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Microchip Biotechnologies Recent Developments and Future Plans
2.11 Myriad Genetics
2.11.1 Myriad Genetics Details
2.11.2 Myriad Genetics Major Business
2.11.3 Myriad Genetics Cancer Genome Sequencing Product and Solutions
2.11.4 Myriad Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Myriad Genetics Recent Developments and Future Plans
2.12 Commonwealth Biotechnologies
2.12.1 Commonwealth Biotechnologies Details
2.12.2 Commonwealth Biotechnologies Major Business
2.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Product and Solutions
2.12.4 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Commonwealth Biotechnologies Recent Developments and Future Plans
2.13 ZS Genetics
2.13.1 ZS Genetics Details
2.13.2 ZS Genetics Major Business
2.13.3 ZS Genetics Cancer Genome Sequencing Product and Solutions
2.13.4 ZS Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 ZS Genetics Recent Developments and Future Plans
2.14 Pacific Biosciences
2.14.1 Pacific Biosciences Details
2.14.2 Pacific Biosciences Major Business
2.14.3 Pacific Biosciences Cancer Genome Sequencing Product and Solutions
2.14.4 Pacific Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Pacific Biosciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Genome Sequencing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Genome Sequencing Players Market Share in 2021
3.2.2 Top 10 Cancer Genome Sequencing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Cancer Genome Sequencing Players Head Office, Products and Services Provided
3.4 Cancer Genome Sequencing Mergers & Acquisitions
3.5 Cancer Genome Sequencing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Genome Sequencing Revenue and Market Share by Type (2017-2022)
4.2 Global Cancer Genome Sequencing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Cancer Genome Sequencing Revenue Market Share by Application (2017-2022)
5.2 Global Cancer Genome Sequencing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Genome Sequencing Revenue by Type (2017-2028)
6.2 North America Cancer Genome Sequencing Revenue by Application (2017-2028)
6.3 North America Cancer Genome Sequencing Market Size by Country
6.3.1 North America Cancer Genome Sequencing Revenue by Country (2017-2028)
6.3.2 United States Cancer Genome Sequencing Market Size and Forecast (2017-2028)
6.3.3 Canada Cancer Genome Sequencing Market Size and Forecast (2017-2028)
6.3.4 Mexico Cancer Genome Sequencing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Genome Sequencing Revenue by Type (2017-2028)
7.2 Europe Cancer Genome Sequencing Revenue by Application (2017-2028)
7.3 Europe Cancer Genome Sequencing Market Size by Country
7.3.1 Europe Cancer Genome Sequencing Revenue by Country (2017-2028)
7.3.2 Germany Cancer Genome Sequencing Market Size and Forecast (2017-2028)
7.3.3 France Cancer Genome Sequencing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Cancer Genome Sequencing Market Size and Forecast (2017-2028)
7.3.5 Russia Cancer Genome Sequencing Market Size and Forecast (2017-2028)
7.3.6 Italy Cancer Genome Sequencing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Genome Sequencing Revenue by Type (2017-2028)
8.2 Asia-Pacific Cancer Genome Sequencing Revenue by Application (2017-2028)
8.3 Asia-Pacific Cancer Genome Sequencing Market Size by Region
8.3.1 Asia-Pacific Cancer Genome Sequencing Revenue by Region (2017-2028)
8.3.2 China Cancer Genome Sequencing Market Size and Forecast (2017-2028)
8.3.3 Japan Cancer Genome Sequencing Market Size and Forecast (2017-2028)
8.3.4 South Korea Cancer Genome Sequencing Market Size and Forecast (2017-2028)
8.3.5 India Cancer Genome Sequencing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Cancer Genome Sequencing Market Size and Forecast (2017-2028)
8.3.7 Australia Cancer Genome Sequencing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Genome Sequencing Revenue by Type (2017-2028)
9.2 South America Cancer Genome Sequencing Revenue by Application (2017-2028)
9.3 South America Cancer Genome Sequencing Market Size by Country
9.3.1 South America Cancer Genome Sequencing Revenue by Country (2017-2028)
9.3.2 Brazil Cancer Genome Sequencing Market Size and Forecast (2017-2028)
9.3.3 Argentina Cancer Genome Sequencing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Genome Sequencing Revenue by Type (2017-2028)
10.2 Middle East & Africa Cancer Genome Sequencing Revenue by Application (2017-2028)
10.3 Middle East & Africa Cancer Genome Sequencing Market Size by Country
10.3.1 Middle East & Africa Cancer Genome Sequencing Revenue by Country (2017-2028)
10.3.2 Turkey Cancer Genome Sequencing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Cancer Genome Sequencing Market Size and Forecast (2017-2028)
10.3.4 UAE Cancer Genome Sequencing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Cancer Genome Sequencing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Cancer Genome Sequencing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Cancer Genome Sequencing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Cancer Genome Sequencing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Cancer Genome Sequencing Revenue Market Share by Region (2023-2028)
Table 6. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 7. Agilent Technologies Major Business
Table 8. Agilent Technologies Cancer Genome Sequencing Product and Solutions
Table 9. Agilent Technologies Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. GE Healthcare Life Sciences Corporate Information, Head Office, and Major Competitors
Table 11. GE Healthcare Life Sciences Major Business
Table 12. GE Healthcare Life Sciences Cancer Genome Sequencing Product and Solutions
Table 13. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Cancer Genome Sequencing Product and Solutions
Table 17. Johnson & Johnson Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. LI-COR Biosciences Corporate Information, Head Office, and Major Competitors
Table 19. LI-COR Biosciences Major Business
Table 20. LI-COR Biosciences Cancer Genome Sequencing Product and Solutions
Table 21. LI-COR Biosciences Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Laboratories Major Business
Table 24. Abbott Laboratories Cancer Genome Sequencing Product and Solutions
Table 25. Abbott Laboratories Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 27. Beckman Coulter Major Business
Table 28. Beckman Coulter Cancer Genome Sequencing Product and Solutions
Table 29. Beckman Coulter Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Bayer Corporate Information, Head Office, and Major Competitors
Table 31. Bayer Major Business
Table 32. Bayer Cancer Genome Sequencing Product and Solutions
Table 33. Bayer Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Hamilton Thorne Biosciences Corporate Information, Head Office, and Major Competitors
Table 35. Hamilton Thorne Biosciences Major Business
Table 36. Hamilton Thorne Biosciences Cancer Genome Sequencing Product and Solutions
Table 37. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors
Table 39. Integrated DNA Technologies Major Business
Table 40. Integrated DNA Technologies Cancer Genome Sequencing Product and Solutions
Table 41. Integrated DNA Technologies Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Microchip Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 43. Microchip Biotechnologies Major Business
Table 44. Microchip Biotechnologies Cancer Genome Sequencing Product and Solutions
Table 45. Microchip Biotechnologies Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 47. Myriad Genetics Major Business
Table 48. Myriad Genetics Cancer Genome Sequencing Product and Solutions
Table 49. Myriad Genetics Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Commonwealth Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 51. Commonwealth Biotechnologies Major Business
Table 52. Commonwealth Biotechnologies Cancer Genome Sequencing Product and Solutions
Table 53. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. ZS Genetics Corporate Information, Head Office, and Major Competitors
Table 55. ZS Genetics Major Business
Table 56. ZS Genetics Cancer Genome Sequencing Product and Solutions
Table 57. ZS Genetics Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Pacific Biosciences Corporate Information, Head Office, and Major Competitors
Table 59. Pacific Biosciences Major Business
Table 60. Pacific Biosciences Cancer Genome Sequencing Product and Solutions
Table 61. Pacific Biosciences Cancer Genome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Cancer Genome Sequencing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Cancer Genome Sequencing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Cancer Genome Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Cancer Genome Sequencing Players Head Office, Products and Services Provided
Table 66. Cancer Genome Sequencing Mergers & Acquisitions in the Past Five Years
Table 67. Cancer Genome Sequencing New Entrants and Expansion Plans
Table 68. Global Cancer Genome Sequencing Revenue (USD Million) by Type (2017-2022)
Table 69. Global Cancer Genome Sequencing Revenue Share by Type (2017-2022)
Table 70. Global Cancer Genome Sequencing Revenue Forecast by Type (2023-2028)
Table 71. Global Cancer Genome Sequencing Revenue by Application (2017-2022)
Table 72. Global Cancer Genome Sequencing Revenue Forecast by Application (2023-2028)
Table 73. North America Cancer Genome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Cancer Genome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Cancer Genome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Cancer Genome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Cancer Genome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Cancer Genome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Cancer Genome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Cancer Genome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Cancer Genome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Cancer Genome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Cancer Genome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Cancer Genome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Cancer Genome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Cancer Genome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Cancer Genome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Cancer Genome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Cancer Genome Sequencing Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Cancer Genome Sequencing Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Cancer Genome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Cancer Genome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Cancer Genome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Cancer Genome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Cancer Genome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Cancer Genome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Cancer Genome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Cancer Genome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Cancer Genome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Cancer Genome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Cancer Genome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Cancer Genome Sequencing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Cancer Genome Sequencing Picture
Figure 2. Global Cancer Genome Sequencing Revenue Market Share by Type in 2021
Figure 3. Second Generation
Figure 4. Third Generation
Figure 5. Cancer Genome Sequencing Revenue Market Share by Application in 2021
Figure 6. Treatment Picture
Figure 7. Research Picture
Figure 8. Global Cancer Genome Sequencing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Cancer Genome Sequencing Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Cancer Genome Sequencing Revenue Market Share by Region (2017-2028)
Figure 11. Global Cancer Genome Sequencing Revenue Market Share by Region in 2021
Figure 12. North America Cancer Genome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Cancer Genome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Cancer Genome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Cancer Genome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Cancer Genome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Cancer Genome Sequencing Market Drivers
Figure 18. Cancer Genome Sequencing Market Restraints
Figure 19. Cancer Genome Sequencing Market Trends
Figure 20. Agilent Technologies Recent Developments and Future Plans
Figure 21. GE Healthcare Life Sciences Recent Developments and Future Plans
Figure 22. Johnson & Johnson Recent Developments and Future Plans
Figure 23. LI-COR Biosciences Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Beckman Coulter Recent Developments and Future Plans
Figure 26. Bayer Recent Developments and Future Plans
Figure 27. Hamilton Thorne Biosciences Recent Developments and Future Plans
Figure 28. Integrated DNA Technologies Recent Developments and Future Plans
Figure 29. Microchip Biotechnologies Recent Developments and Future Plans
Figure 30. Myriad Genetics Recent Developments and Future Plans
Figure 31. Commonwealth Biotechnologies Recent Developments and Future Plans
Figure 32. ZS Genetics Recent Developments and Future Plans
Figure 33. Pacific Biosciences Recent Developments and Future Plans
Figure 34. Global Cancer Genome Sequencing Revenue Share by Players in 2021
Figure 35. Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Cancer Genome Sequencing Revenue Market Share in 2021
Figure 37. Global Top 10 Players Cancer Genome Sequencing Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Cancer Genome Sequencing Revenue Share by Type in 2021
Figure 40. Global Cancer Genome Sequencing Market Share Forecast by Type (2023-2028)
Figure 41. Global Cancer Genome Sequencing Revenue Share by Application in 2021
Figure 42. Global Cancer Genome Sequencing Market Share Forecast by Application (2023-2028)
Figure 43. North America Cancer Genome Sequencing Sales Market Share by Type (2017-2028)
Figure 44. North America Cancer Genome Sequencing Sales Market Share by Application (2017-2028)
Figure 45. North America Cancer Genome Sequencing Revenue Market Share by Country (2017-2028)
Figure 46. United States Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Cancer Genome Sequencing Sales Market Share by Type (2017-2028)
Figure 50. Europe Cancer Genome Sequencing Sales Market Share by Application (2017-2028)
Figure 51. Europe Cancer Genome Sequencing Revenue Market Share by Country (2017-2028)
Figure 52. Germany Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Cancer Genome Sequencing Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Cancer Genome Sequencing Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Cancer Genome Sequencing Revenue Market Share by Region (2017-2028)
Figure 60. China Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Cancer Genome Sequencing Sales Market Share by Type (2017-2028)
Figure 67. South America Cancer Genome Sequencing Sales Market Share by Application (2017-2028)
Figure 68. South America Cancer Genome Sequencing Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Cancer Genome Sequencing Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Cancer Genome Sequencing Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Cancer Genome Sequencing Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Cancer Genome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
